Botulism Outbreak Linked to Infant Formula
Parents of infants should be aware that 50 hospitalizations were linked to two specific formula brands.
Updated on Oct. 5, 2026 in Babies
Live Poll
Should federal regulators mandate stricter botulism testing for all infant formula manufacturers?
The FDA recently concluded an investigation into a botulism outbreak that resulted in the hospitalization of 50 babies. The investigation identified infant formula brands ByHeart and Nara as the products linked to the illnesses.
Why it matters
This investigation highlights significant gaps in food safety oversight as there is currently no industry-wide mandate for testing powdered infant formula for botulism. The findings draw attention to the complexities of supply chain transparency for essential nutrition products.
The outbreak involved 50 hospitalizations connected to milk ingredients traced back to 22 separate dairies. While reports of botulism linked to formula exist in FDA databases dating back over 20 years, no industry-wide testing requirement currently exists.
The players
FDA
The federal agency responsible for protecting public health by ensuring the safety and security of the nation's food supply.
ByHeart
A manufacturer of infant formula that reported having no direct visibility or control over specific dairy farms chosen by its suppliers.
Nara
An infant formula brand implicated in the FDA investigation into recent botulism cases.
The details
Investigators traced the source of the contamination through the supply chain back to 22 dairies. The brands involved, ByHeart and Nara, reportedly lacked direct visibility or control over the specific farms chosen by their milk suppliers. Companies are now responding by switching milk suppliers and developing new internal testing protocols to prevent future contamination.
Timeline
Three years ago, the first infection in the outbreak occurred.
In 2023, the FDA issued a warning to the infant formula industry regarding botulism.
In 2001, Kevin Kowalcyk died from E. coli.
The Home Front
This event highlights the gap in federal food safety standards regarding mandatory botulism testing for infant formula manufacturers. Congress is currently considering legislation that would establish an industry-wide mandate to close this safety loophole.
If you are concerned about the safety of your infant's formula, consult your pediatrician for guidance on safe feeding alternatives. Monitor official FDA communications for any future updates regarding supply chain protocols and testing requirements.
The takeaway
Food safety in the nursery remains a priority, as manufacturers continue to update testing protocols to address supply chain vulnerabilities. Stay informed by tracking the progress of pending legislation that aims to mandate industry-wide testing for botulism.
Further reading
For more on keeping your nursery safe, visit our Babies section.
Source note: This article includes information reported by The National Desk.
Live Poll
Should federal regulators mandate stricter botulism testing for all infant formula manufacturers?
